Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Anne Capp"'
Autor:
Michael Peter Jones, George Hruby, Ur Metser, Swetha Sridharan, Anne Capp, Mahesh Kumar, Sarah Gallagher, Natalie Rutherford, Carl Holder, Christopher Oldmeadow, Jarad Martin
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Background To investigate the prognostic significance of positron emission tomography (PET) parameters from F-18 fluorodeoxyglucose (FDG) PET scans performed pre- and post- chemo-radiotherapy (CRT) for squamous cell carcinoma of the anal can
Externí odkaz:
https://doaj.org/article/0db9cef16ede4089b2e036d7e4517b12
Autor:
Peter O’Brien, John F. Seymour, Richard W. Tsang, Anne Capp, Michael MacManus, Mathias Bressel, Andrew Wirth, Stephen Lade, Daniel Roos
Publikováno v:
European Journal of Cancer. 152:129-138
Background This Phase 2 multicentre trial in localised non-gastric marginal zone lymphoma (MZL) evaluated the effectiveness and safety of radiotherapy and documented markers of autoimmunity and Helicobacter pylori infection. Patients and methods Elig
Autor:
Christopher Oldmeadow, Brandon Driscoll, Peter Stanwell, Michael P. Jones, Swetha Sridharan, Anne Capp, George Hruby, Jarad Martin, Sarah Gallagher, Catherine Coolens, Jameen Arm, Mahesh Kumar, Carl Holder
Publikováno v:
Radiotherapy and Oncology. 144:7-12
Background and purpose To investigate the role of multi-parametric magnetic resonance imaging (MP-MRI) as a biomarker for squamous cell carcinoma of the anal canal (SCCAC). Materials and methods From January 2013 to January 2017, 25 patients with non
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 63:683-690
INTRODUCTION Fatigue is a commonly reported symptom in men receiving radiation therapy and androgen deprivation therapy (ADT) for prostate cancer. Despite this, the complex mechanisms remain unclear. This study aims to investigate factors which corre
Autor:
Carien L. Creutzberg, Petronella B. Ottevanger, Annamaria Ferrero, Luis Souhami, Pearly Khaw, GH Westerveld, Diane Provencher, Gillian Thomas, Jan Pyman, V. Do, Annerie Slot, C Davidson, G. Wilson, Stephanie M. de Boer, Peter Hoskin, C M McLachlin, Michael A. Quinn, Deborah Gregory, Remi A. Nout, Hans W. Nijman, J.J. Jobsen, Tanja C. Stam, Vincent T.H.B.M. Smit, K Whitmarsh, Paul Bessette, Roy F.P.M. Kruitwagen, W Taylor, Dionyssios Katsaros, Chantal Hanzen, Henry C Kitchener, M McCormack, Prafull Ghatage, Dominique Berton-Rigaud, J.W.M. Mens, Melanie E Powell, Elisabeth Pras, Jonathan A. Ledermann, Karen W Verhoeven-Adema, Harmen Hollema, Andrea Lissoni, Linda Mileshkin, Anjana Anand, Amanda Feeney, Sergio Gribaudo, Marie-Helene Baron, R Allerton, Hein Putter, Colin D. Johnson, P. Symonds, Ina M. Jürgenliemk-Schulz, Romerai D'Amico, Ilka Kolodziej, M Adusumalli, Naveena Singh, G Artioli, An Snyers, R Wade, Christine Haie-Meder, Roldano Fossati, Nicole Tubiana-Mathieu, Anthony Fyles, Silvestro Carinelli, Anne Capp, Alexandra J. Stewart, Kaj De Winter, B. van Triest, L.C.H.W. Lutgens, Susan Brooks, E. Van der Steen-Banasik, Pierre Duvillard, Pvc Rittenberg, Alessandro Colombo
Publikováno v:
Lancet Oncology, 20, 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
BACKGROUND:The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and
Autor:
Jarad Martin, Mark Sidhom, Colin Tang, Shankar Siva, Amy Hayden, Anne Capp, David Pryor, J. Tomaszewski, A. Miller, Yuvnik Trada, Peter B. Greer, S. Sridaran, Paul J. Keall
Publikováno v:
Radiotherapy and Oncology. 158:S20-S21
Autor:
Gisela Mautner, Zaza Mezvrishvili, Marinella Messina, Paul de Souza, Anne Capp, Nana Chikhladze
Publikováno v:
Journal of Clinical Oncology. 38:5533-5533
5533 Background: NOX66 is a new formulation of the small molecule, idronoxil. The primary mechanism of action of idronoxil stems from its binding to the transmembrane enzyme ENOX2 expressed on cancer cells, resulting in reduced S1P and increased cera
Autor:
Anoop K Enjeti, Anne Capp, Elizabeth G. Holliday, C. Lapuz, Peter C. O'Brien, Sanjiv A. Gupta
Publikováno v:
Blood and Lymphatic Cancer: Targets and Therapy
Carminia Lapuz,1–3 Anoop K Enjeti,2,4 Peter C O’Brien,1,2 Anne L Capp,1,2 Elizabeth G Holliday,2,5 Sanjiv A Gupta1,2 1Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, NSW, Australia; 2Faculty of Medicine and Public Health, Un
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 59:631-639
Introduction Retrospective analysis was performed at a single institution to assess the responsiveness of mantle cell lymphoma (MCL) to involved-field radiotherapy (IFRT). Methods All patients treated with IFRT to at least one site of MCL between 199
Publikováno v:
Australasian Physical & Engineering Sciences in Medicine. 37:705-712
To evaluate cervix brachytherapy dosimetry with the introduction of magnetic resonance (MR) based treatment planning and volumetric prescriptions and propose a method for plan evaluation in the transition period. The treatment records of 69 patients